Eledon Pharmaceuticals, Inc. (ELDN)

Augmedix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8.5	20.55	4.61	56.41	84.83	114.2
Short-Term Investments	116.39	119.63	46.49	-	-	-
Cash & Short-Term Investments	124.88	140.18	51.1	56.41	84.83	114.2
Cash Growth	191.36%	174.31%	-9.41%	-33.51%	-25.71%	1199.00%
Other Receivables	0.76	-	-	-	-	0.11
Receivables	0.76	-	-	-	-	0.11
Prepaid Expenses	2.02	2.82	4.94	3.08	3.48	1.29
Other Current Assets	0.06	0.73	0.09	0.03	0.03	0.04
Total Current Assets	127.72	143.73	56.13	59.52	88.35	115.63
Property, Plant & Equipment	0.85	0.93	0.37	0.74	0.77	0.14
Goodwill	-	-	-	-	48.65	48.65
Other Intangible Assets	32.39	32.39	32.39	32.39	32.39	32.39
Other Long-Term Assets	0.35	0.36	0.19	0.15	0.4	0.38
Total Assets	161.31	177.41	89.07	92.79	170.55	197.19
Accounts Payable	2.9	5.83	0.97	2.2	1.81	1.37
Accrued Expenses	5.96	5.43	2.55	3.91	2.22	0.97
Current Portion of Leases	0.33	0.31	0.38	0.36	0.37	0.14
Total Current Liabilities	9.19	11.58	3.9	6.48	4.4	2.48
Long-Term Leases	0.56	0.64	-	0.38	0.4	-
Long-Term Deferred Tax Liabilities	2.18	2.18	1.75	1.75	1.75	4.11
Other Long-Term Liabilities	34.81	44.87	76.21	-	-	-
Total Liabilities	46.73	59.27	81.86	8.61	6.55	6.59
Common Stock	0.06	0.06	0.02	0.01	0.01	0.02
Additional Paid-In Capital	476.62	473.64	326.59	287.03	278.88	270.97
Retained Earnings	-362.08	-355.59	-319.4	-202.87	-114.9	-80.39
Comprehensive Income & Other	-0.02	0.03	-	-	-	-
Total Common Equity	114.58	118.14	7.21	84.18	164	190.6
Shareholders' Equity	114.58	118.14	7.21	84.18	164	190.6
Total Liabilities & Equity	161.31	177.41	89.07	92.79	170.55	197.19
Total Debt	0.88	0.95	0.38	0.75	0.77	0.14
Net Cash (Debt)	124	139.22	50.72	55.66	84.06	114.05
Net Cash Growth	191.23%	174.50%	-8.88%	-33.78%	-26.29%	1247.01%
Net Cash Per Share	2.06	2.87	2.06	3.90	5.67	78.58
Filing Date Shares Outstanding	59.88	59.88	24.81	13.78	14.31	14.31
Total Common Shares Outstanding	59.88	59.79	24.21	13.78	14.31	15.16
Working Capital	118.53	132.15	52.23	53.04	83.95	113.15
Book Value Per Share	1.91	1.98	0.30	6.11	11.46	12.57
Tangible Book Value	82.19	85.75	-25.18	51.8	82.96	109.56
Tangible Book Value Per Share	1.37	1.43	-1.04	3.76	5.80	7.23

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q